-
1
-
-
0027389140
-
Cell-growth regulation in epithelial ovarian-cancer
-
Bast, R.C., C.M. Boyer, I. Jacobs, F.J. Xu, S. Wu, J. Wiener, M. Kohler, and A. Berchuck. 1993. Cell-growth regulation in epithelial ovarian-cancer. Cancer 71: 1597-1601.
-
(1993)
Cancer
, vol.71
, pp. 1597-1601
-
-
Bast, R.C.1
Boyer, C.M.2
Jacobs, I.3
Xu, F.J.4
Wu, S.5
Wiener, J.6
Kohler, M.7
Berchuck, A.8
-
2
-
-
0344591720
-
Tumour suppressor genes and cellular senescence in ovarian cancer
-
ed. F. Sharp, P. Mason, T. Blackett, and J. Berek, Chapman and Hall, London, UK
-
Black, D., J. Watson, and A. Hurlestone. 1998. Tumour suppressor genes and cellular senescence in ovarian cancer. In Ovarian cancer 5 (ed. F. Sharp, P. Mason, T. Blackett, and J. Berek), pp. 49-66. Chapman and Hall, London, UK.
-
(1998)
Ovarian Cancer
, vol.5
, pp. 49-66
-
-
Black, D.1
Watson, J.2
Hurlestone, A.3
-
3
-
-
12644252939
-
Integrated radiation hybrid and yeast artificial chromosome map of chromosome 9p
-
Bouzyk, M., S. Bryant, C. Evans, S. Guioli, S. Ford, K. Schmidt, P. Goodfellow, S. Povey, M. Rebello, S. Rousseaux et al. 1997. Integrated radiation hybrid and yeast artificial chromosome map of chromosome 9p. Eur. J. Hum. Genet. 5: 299-307.
-
(1997)
Eur. J. Hum. Genet.
, vol.5
, pp. 299-307
-
-
Bouzyk, M.1
Bryant, S.2
Evans, C.3
Guioli, S.4
Ford, S.5
Schmidt, K.6
Goodfellow, P.7
Povey, S.8
Rebello, M.9
Rousseaux, S.10
-
4
-
-
0029091503
-
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
-
Cairns, P., T.J. Polascik, Y. Eby, K. Tokino, J. Califano, A. Merlo, L. Mao, J. Herath, R. Jenkins, W. Westra et al. 1995. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet. 11: 210-212.
-
(1995)
Nat. Genet.
, vol.11
, pp. 210-212
-
-
Cairns, P.1
Polascik, T.J.2
Eby, Y.3
Tokino, K.4
Califano, J.5
Merlo, A.6
L, M.7
Herath, J.8
Jenkins, R.9
Westra, W.10
-
5
-
-
0028059330
-
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
-
Caldas, C., S.A. Hahn, LT. da Costa, M.S. Redston, M. Schutte, A.B. Seymour, C.L. Weinstein, R.H. Hruban, C.J. Yeo, and S.E. Kern. 1994. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet. 8: 27-32.
-
(1994)
Nat. Genet.
, vol.8
, pp. 27-32
-
-
Caldas, C.1
Hahn, S.A.2
Da Costa, L.T.3
Redston, M.S.4
Schutte, M.5
Seymour, A.B.6
Weinstein, C.L.7
Hruban, R.H.8
Yeo, C.J.9
Kern, S.E.10
-
6
-
-
0028820566
-
LOH and mutation analysis of CDKN2 in primary human ovarian cancers
-
Campbell, I.G., G. Beynon, M. Davis, and P. Englefield. 1995. LOH and mutation analysis of CDKN2 in primary human ovarian cancers. Int. J. Cancer 63: 222-225.
-
(1995)
Int. J. Cancer
, vol.63
, pp. 222-225
-
-
Campbell, I.G.1
Beynon, G.2
Davis, M.3
Englefield, P.4
-
7
-
-
23444436135
-
Non-surgical aspects of ovarian cancer
-
Chang, J., J. Bridgewater, M. Gore, C. Fisher, J. Schofield, R. A'hern, B. Ponder, I. Jocobs, M. McKeage, and L. Kelland et al. 1994. Non-surgical aspects of ovarian cancer. Lancet 343: 335-341.
-
(1994)
Lancet
, vol.343
, pp. 335-341
-
-
Chang, J.1
Bridgewater, J.2
Gore, M.3
Fisher, C.4
Schofield, J.5
A'hern, R.6
Ponder, B.7
Jocobs, I.8
McKeage, M.9
Kelland, L.10
-
8
-
-
0027963502
-
Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors
-
Chenevix-Trench, G., J. Kerr, M. Friedlander, T. Hurst, B. Sanderson, M. Coglan, B. Ward, J. Leary, and S.K. Khoo. 1994. Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors. Am. J. Hum. Genet. 55: 143-149.
-
(1994)
Am. J. Hum. Genet.
, vol.55
, pp. 143-149
-
-
Chenevix-Trench, G.1
Kerr, J.2
Friedlander, M.3
Hurst, T.4
Sanderson, B.5
Coglan, M.6
Ward, B.7
Leary, J.8
Khoo, S.K.9
-
9
-
-
0031014476
-
Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: Clinicopathological correlations
-
Chenevix-Trench, G., J. Kerr, T. Hurst, Y.C. Shih, D. Purdie, L. Bergman, M. Friedlander, B. Sanderson, A. Zournazi, and T. Coombs et al. 1997. Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: Clinicopathological correlations. Genes Chromosomes Cancer 18: 75-83.
-
(1997)
Genes Chromosomes Cancer
, vol.18
, pp. 75-83
-
-
Chenevix-Trench, G.1
Kerr, J.2
Hurst, T.3
Shih, Y.C.4
Purdie, D.5
Bergman, L.6
Friedlander, M.7
Sanderson, B.8
Zournazi, A.9
Coombs, T.10
-
10
-
-
0031424074
-
Molecular genetic events in the development and progression of ovarian cancer in humans
-
Chuaqui, R.F., Z. Zhuang, and M.J. Merino. 1997. Molecular genetic events in the development and progression of ovarian cancer in humans. Mol. Med. Today 3: 207-213.
-
(1997)
Mol. Med. Today
, vol.3
, pp. 207-213
-
-
Chuaqui, R.F.1
Zhuang, Z.2
Merino, M.J.3
-
11
-
-
0021058774
-
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors
-
Hamilton, T.C., R.C. Young, W.M. McKoy, K.R. Grotzinger, J.A. Green, E.W. Chu, J. Whang-Peng, A.M. Rogan, W.R. Green, and R.F. Ozols. 1983. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 43: 5379-5389.
-
(1983)
Cancer Res.
, vol.43
, pp. 5379-5389
-
-
Hamilton, T.C.1
Young, R.C.2
McKoy, W.M.3
Grotzinger, K.R.4
Green, J.A.5
Chu, E.W.6
Whang-Peng, J.7
Rogan, A.M.8
Green, W.R.9
Ozols, R.F.10
-
12
-
-
0028845142
-
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
-
Herman, J.G., A. Merlo, L. Mao, R.G. Lapidus, J.P. Issa, N.E. Davidson, D. Sidransky, and S.B. Baylin. 1995. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55: 4525-4530.
-
(1995)
Cancer Res.
, vol.55
, pp. 4525-4530
-
-
Herman, J.G.1
Merlo, A.2
Mao, L.3
Lapidus, R.G.4
Issa, J.P.5
Davidson, N.E.6
Sidransky, D.7
Baylin, S.B.8
-
13
-
-
8044224019
-
Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors
-
Ichikawa, Y., S. Yoshida, Y. Koyama, M. Hirai, T. Ishikawa, M. Nishida, H. Tsunoda, T. Kubo, M. Miwa, and K. Uchida. 1996. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors. Int. J. Cancer 69: 466-470.
-
(1996)
Int. J. Cancer
, vol.69
, pp. 466-470
-
-
Ichikawa, Y.1
Yoshida, S.2
Koyama, Y.3
Hirai, M.4
Ishikawa, T.5
Nishida, M.6
Tsunoda, H.7
Kubo, T.8
Miwa, M.9
Uchida, K.10
-
14
-
-
0028858337
-
Genetic analysis of benign, low-grade, and high-grade ovarian tumors
-
Iwabuchi, H., M. Sakamoto, H. Sakunaga, Y.Y. Ma, M.L. Carcangiu, D. Pinkel, T.L. Yang-Feng, and J.W. Gray. 1995. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55: 6172-6180.
-
(1995)
Cancer Res.
, vol.55
, pp. 6172-6180
-
-
Iwabuchi, H.1
Sakamoto, M.2
Sakunaga, H.3
Ma, Y.Y.4
Carcangiu, M.L.5
Pinkel, D.6
Yang-Feng, T.L.7
Gray, J.W.8
-
15
-
-
0027966172
-
Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors
-
Kallioniemi, O.P., A. Kallioniemi, J. Piper, J. Isola, F.M. Waldman, J.W. Gray, and D. Pinkel. 1994. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243.
-
(1994)
Genes Chromosomes Cancer
, vol.10
, pp. 231-243
-
-
Kallioniemi, O.P.1
Kallioniemi, A.2
Piper, J.3
Isola, J.4
Waldman, F.M.5
Gray, J.W.6
Pinkel, D.7
-
16
-
-
0028121279
-
A cell cycle regulator potentially involved in genesis of many tumor types
-
Kamb, A., N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stockert, R.R. Day, B.E. Johnson, and M.H. Skolnick 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
-
(1994)
Science
, vol.264
, pp. 436-440
-
-
Kamb, A.1
Gruis, N.A.2
Weaver-Feldhaus, J.3
Liu, Q.4
Harshman, K.5
Tavtigian, S.V.6
Stockert, E.7
Day, R.R.8
Johnson, B.E.9
Skolnick, M.H.10
-
17
-
-
0023816378
-
Characterization and properties of nine human ovarian adenocarcinoma cell lines
-
Langdon, S., S. Lawrie, F. Hay, M. Hawkes, A. McDonald, I. Hayward, D. Schol, J. Hilgers, R. Leonard, and J. Smyth. 1988. Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res. 48: 6166-6172.
-
(1988)
Cancer Res.
, vol.48
, pp. 6166-6172
-
-
Langdon, S.1
Lawrie, S.2
Hay, F.3
Hawkes, M.4
McDonald, A.5
Hayward, I.6
Schol, D.7
Hilgers, J.8
Leonard, R.9
Smyth, J.10
-
18
-
-
0030936323
-
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
-
Li, J., C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, and R. McCombie et al. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947.
-
(1997)
Science
, vol.275
, pp. 1943-1947
-
-
Li, J.1
Yen, C.2
Liaw, D.3
Podsypanina, K.4
Bose, S.5
Wang, S.I.6
Puc, J.7
Miliaresis, C.8
Rodgers, L.9
McCombie, R.10
-
19
-
-
0029164359
-
Representational difference analysis in detection of genetic lesions in cancer
-
Lisitsyn, N. and M. Wigler. 1995. Representational difference analysis in detection of genetic lesions in cancer. Methods Enzymol. 254: 291-304.
-
(1995)
Methods Enzymol.
, vol.254
, pp. 291-304
-
-
Lisitsyn, N.1
Wigler, M.2
-
20
-
-
0027468779
-
Cloning the differences between two complex genomes
-
Lisitsyn, N., N. Lisitsyn, and M. Wigler. 1993. Cloning the differences between two complex genomes. Science 259: 946-951.
-
(1993)
Science
, vol.259
, pp. 946-951
-
-
Lisitsyn, N.1
Lisitsyn, N.2
Wigler, M.3
-
21
-
-
0029132958
-
Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: Correlation with tumour progression and nm23 gene expression
-
Mandai, M., I. Konishi, T. Komatsu, T. Mori, S. Arao, H. Nomura, Y. Kanda, H. Hiai, and M. Fukumoto. 1995. Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: Correlation with tumour progression and nm23 gene expression. Br. J. Cancer 72: 691-695.
-
(1995)
Br. J. Cancer
, vol.72
, pp. 691-695
-
-
Mandai, M.1
Konishi, I.2
Komatsu, T.3
Mori, T.4
Arao, S.5
Nomura, H.6
Kanda, Y.7
Hiai, H.8
Fukumoto, M.9
-
22
-
-
0028960025
-
Somatic mutations in the BRCA1 gene in sporadi ovarian tumours
-
Merajver, S.D., T.M. Pham, R.F. Caduff, M. Chen, E.L. Poy, K.A. Cooney, B.L. Weber, F.S. Collins, C. Johnston, and T.S. Frank. 1995. Somatic mutations in the BRCA1 gene in sporadi ovarian tumours. Nat. Genet. 9: 439-443.
-
(1995)
Nat. Genet.
, vol.9
, pp. 439-443
-
-
Merajver, S.D.1
Pham, T.M.2
Caduff, R.F.3
Chen, M.4
Poy, E.L.5
Cooney, K.A.6
Weber, B.L.7
Collins, F.S.8
Johnston, C.9
Frank, T.S.10
-
23
-
-
0029011539
-
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
-
Merlo, A., J.G. Herman, L. Mao, D.J. Lee, E. Gabrielson, P.C. Burger, S.B. Baylin, and D. Sidransky. 1995. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1: 686-692.
-
(1995)
Nat. Med.
, vol.1
, pp. 686-692
-
-
Merlo, A.1
Herman, J.G.2
Mao, L.3
Lee, D.J.4
Gabrielson, E.5
Burger, P.C.6
Baylin, S.B.7
Sidransky, D.8
-
24
-
-
0028275733
-
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
-
Nobori, T., K. Miura, D.J. Wu, A. Lois, K. Takabayashi, and D.A. Carson. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756.
-
(1994)
Nature
, vol.368
, pp. 753-756
-
-
Nobori, T.1
Miura, K.2
Wu, D.J.3
Lois, A.4
Takabayashi, K.5
Carson, D.A.6
-
25
-
-
13344279424
-
The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers
-
Ohta, M., H. Inoue, M. Cotticelli, K. Kastury, R. Baffa, J. Palazzo, Z. Siprashvili, M. Mori, P. McCue, and T. Druck et al. 1996. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597.
-
(1996)
Cell
, vol.84
, pp. 587-597
-
-
Ohta, M.1
Inoue, H.2
Cotticelli, M.3
Kastury, K.4
Baffa, R.5
Palazzo, J.6
Siprashvili, Z.7
Mori, M.8
McCue, P.9
Druck, T.10
-
26
-
-
0028907211
-
Computer image analysis of comparative genomic hybridization
-
Piper, J., D. Rutovitz, D. Sudar, A. Kallioniemi, O.P. Kallioniemi, F.M. Waldman, J.W. Gray, and D. Pinkel. 1995. Computer image analysis of comparative genomic hybridization. Cytometry 19: 10-26.
-
(1995)
Cytometry
, vol.19
, pp. 10-26
-
-
Piper, J.1
Rutovitz, D.2
Sudar, D.3
Kallioniemi, A.4
Kallioniemi, O.P.5
Waldman, F.M.6
Gray, J.W.7
Pinkel, D.8
-
27
-
-
0027177858
-
Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer
-
Provencher, D.M., C.L. Finstad, P.E. Saigo, S.C. Rubin, W.J. Hoskins, M.G. Federici, E. Stockert, K.O. Lloyd, and J. Lewis, Jr. 1993. Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer. Gynecol. Oncol. 50: 78-83.
-
(1993)
Gynecol. Oncol.
, vol.50
, pp. 78-83
-
-
Provencher, D.M.1
Finstad, C.L.2
Saigo, P.E.3
Rubin, S.C.4
Hoskins, W.J.5
Federici, M.G.6
Stockert, E.7
Lloyd, K.O.8
Lewis J., Jr.9
-
28
-
-
0029017087
-
Chromosome 9p deletions in cutaneous malignant melanoma tumors: The minimal deleted region involves markers outside the p16 (CDKN2) gene
-
Puig, S., A. Ruiz, C. Lazaro, T. Castel, M. Lynch, J. Palou, A. Vilalta, J. Weissenbach, J.M. Mascaro, and X. Estivill. 1995. Chromosome 9p deletions in cutaneous malignant melanoma tumors: The minimal deleted region involves markers outside the p16 (CDKN2) gene. Am. J. Hum. Genet. 57: 395-402.
-
(1995)
Am. J. Hum. Genet.
, vol.57
, pp. 395-402
-
-
Puig, S.1
Ruiz, A.2
Lazaro, C.3
Castel, T.4
Lynch, M.5
Palou, J.6
Vilalta, A.7
Weissenbach, J.8
Mascaro, J.M.9
Estivill, X.10
-
29
-
-
0028100547
-
Mutations of the E-cadherin gene in human gynecologic cancers
-
Risinger, J.I., A. Berchuck, M.F. Kohler, and J. Boyd. 1994. Mutations of the E-cadherin gene in human gynecologic cancers. Nat. Genet. 7: 98-102.
-
(1994)
Nat. Genet.
, vol.7
, pp. 98-102
-
-
Risinger, J.I.1
Berchuck, A.2
Kohler, M.F.3
Boyd, J.4
-
30
-
-
0028850649
-
Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors
-
Rodabaugh, K.J., R.B. Biggs, J.A. Qureshi, A.J. Barrett, W.R. Welch, D.A. Bell, R.S. Berkowitz, and S.C. Mok. 1995. Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. Oncogene 11: 1249-1254.
-
(1995)
Oncogene
, vol.11
, pp. 1249-1254
-
-
Rodabaugh, K.J.1
Biggs, R.B.2
Qureshi, J.A.3
Barrett, A.J.4
Welch, W.R.5
Bell, D.A.6
Berkowitz, R.S.7
Mok, S.C.8
-
31
-
-
0029024708
-
Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2
-
Schultz, D.C., L. Vanderveer, K.H. Buetow, M.P. Boente, R.F. Ozols, T.C. Hamilton, and A.K. Godwin. 1995. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Cancer Res. 55: 2150-2157.
-
(1995)
Cancer Res.
, vol.55
, pp. 2150-2157
-
-
Schultz, D.C.1
Vanderveer, L.2
Buetow, K.H.3
Boente, M.P.4
Ozols, R.F.5
Hamilton, T.C.6
Godwin, A.K.7
-
32
-
-
0029041032
-
Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region
-
Schutte, M., L.T. da-Costa, S.A. Hahn, C. Moskaluk, A.T. Hoque, E. Rozenblum, C.L. Weinstein, M. Bittner, P.S. Meltzer, and J.M. Trent et al. 1995. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Prof. Natl. Acad. Sci. 92: 5950-5954.
-
(1995)
Prof. Natl. Acad. Sci.
, vol.92
, pp. 5950-5954
-
-
Schutte, M.1
Da-Costa, L.T.2
Hahn, S.A.3
Moskaluk, C.4
Hoque, A.T.5
Rozenblum, E.6
Weinstein, C.L.7
Bittner, M.8
Meltzer, P.S.9
Trent, J.M.10
-
33
-
-
0027769876
-
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
-
Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
-
(1993)
Nature
, vol.366
, pp. 704-707
-
-
Serrano, M.1
Hannon, G.J.2
Beach, D.3
-
34
-
-
0030895616
-
Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours
-
Shih, Y.C., J. Kerr, J. Liu, T. Hurst, S.K. Khoo, B. Ward, B. Wainwright, and G. Chenevix-Trench. 1997. Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours. Int. J. Cancer 70: 508-511.
-
(1997)
Int. J. Cancer
, vol.70
, pp. 508-511
-
-
Shih, Y.C.1
Kerr, J.2
Liu, J.3
Hurst, T.4
Khoo, S.K.5
Ward, B.6
Wainwright, B.7
Chenevix-Trench, G.8
-
35
-
-
0024337144
-
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
-
Slamon, D.J., W. Godolphin, L.A. Jones, J.A. Holt, S.G. Wong, D.E. Keith, W.J. Levin, S.G. Stuart, J. Udove, and A. Ullrich. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712.
-
(1989)
Science
, vol.244
, pp. 707-712
-
-
Slamon, D.J.1
Godolphin, W.2
Jones, L.A.3
Holt, J.A.4
Wong, S.G.5
Keith, D.E.6
Levin, W.J.7
Stuart, S.G.8
Udove, J.9
Ullrich, A.10
-
36
-
-
17144436629
-
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
-
Steck, P.A., M.A. Pershouse, S.A. Jasser, W.K. Yung, H. Lin, A.H. Ligon, L.A. Langford, M.L. Baumgard, T. Hattier, and T. Davis et al. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15: 356-362.
-
(1997)
Nat. Genet.
, vol.15
, pp. 356-362
-
-
Steck, P.A.1
Pershouse, M.A.2
Jasser, S.A.3
Yung, W.K.4
Lin, H.5
Ligon, A.H.6
Langford, L.A.7
Baumgard, M.L.8
Hattier, T.9
Davis, T.10
-
37
-
-
0345022773
-
Oncogenes and tumour suppressor genes in ovarian cancer
-
ed. S. Langdon, W. Miller, and A. Berchuck, CRC Press LLC, New York, NY
-
Steel, C.and H. Gabra. 1997. Oncogenes and tumour suppressor genes in ovarian cancer. In Biology of female cancers (ed. S. Langdon, W. Miller, and A. Berchuck), pp. 133-152. CRC Press LLC, New York, NY.
-
(1997)
Biology of Female Cancers
, pp. 133-152
-
-
Steel, C.1
Gabra, H.2
-
38
-
-
0029009749
-
Mutation analysis of BRCA1 gene in ovarian cancers
-
Takahashi, H., K. Behbakht, P.E. McGovern, H.-S. Chiu, F.J. Couch, B.L. Weber, L.S. Friedman, M.-C. King, M. Furusato, and V.A. LiVolsi et al. 1995. Mutation analysis of BRCA1 gene in ovarian cancers. Cancer Res. 55: 2998-3002.
-
(1995)
Cancer Res.
, vol.55
, pp. 2998-3002
-
-
Takahashi, H.1
Behbakht, K.2
McGovern, P.E.3
Chiu, H.-S.4
Couch, F.J.5
Weber, B.L.6
Friedman, L.S.7
King, M.-C.8
Furusato, M.9
LiVolsi, V.A.10
-
39
-
-
9344244079
-
Mutations of the BRCA2 gene in ovarian carcinomas
-
Takahashi, H., H.C. Chiu, C.A. Bandera, K. Behbakht, P.C. Liu, F.J. Couch, B.L. Weber, V.A. LiVolsi, M. Furusato, and B.A. Rebane et al. 1996. Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res. 56: 2738-2741.
-
(1996)
Cancer Res.
, vol.56
, pp. 2738-2741
-
-
Takahashi, H.1
Chiu, H.C.2
Bandera, C.A.3
Behbakht, K.4
Liu, P.C.5
Couch, F.J.6
Weber, B.L.7
LiVolsi, V.A.8
Furusato, M.9
Rebane, B.A.10
-
40
-
-
0030969847
-
Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas
-
Tapper, J., R. Butzow, T. Wahlstrom, M. Seppala, and S. Knuutila. 1997. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas. Br. J. Cancer 75: 1782-1787.
-
(1997)
Br. J. Cancer
, vol.75
, pp. 1782-1787
-
-
Tapper, J.1
Butzow, R.2
Wahlstrom, T.3
Seppala, M.4
Knuutila, S.5
-
41
-
-
0027182705
-
p53 and Ki-ras gene mutations in epithelial ovarian neoplasms
-
Teneriello, M.G., M. Ebina, R.I. Linnoila, M. Henry, J.D. Nash, R.C. Park, and M.J. Birrer. 1993. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res. 53: 3103-3108.
-
(1993)
Cancer Res.
, vol.53
, pp. 3103-3108
-
-
Teneriello, M.G.1
Ebina, M.2
Linnoila, R.I.3
Henry, M.4
Nash, J.D.5
Park, R.C.6
Birrer, M.J.7
-
42
-
-
0031980540
-
Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets
-
Walker, G.J., J.F. Flores, J.M. Glendening, A. Lin, I.D.C. Markl, and J.W. Fountain. 1998. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets. Genes Chromosomes Cancer 22: 157-163.
-
(1998)
Genes Chromosomes Cancer
, vol.22
, pp. 157-163
-
-
Walker, G.J.1
Flores, J.F.2
Glendening, J.M.3
Lin, A.4
Markl, I.D.C.5
Fountain, J.W.6
-
43
-
-
0027958821
-
Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas
-
Weaver-Feldhaus, J., N.A. Gruis, S. Neuhausen, D. Le Paslier, E. Stockert, M.H. Skolnick, and A. Kamb. 1994. Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc. Natl. Acad. Sci. 91: 7563-7567.
-
(1994)
Proc. Natl. Acad. Sci.
, vol.91
, pp. 7563-7567
-
-
Weaver-Feldhaus, J.1
Gruis, N.A.2
Neuhausen, S.3
Le Paslier, D.4
Stockert, E.5
Skolnick, M.H.6
Kamb, A.7
-
44
-
-
0029146575
-
p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer
-
Williamson, M.P., P.A. Elder, M.E. Shaw, J. Devlin, and M.A. Knowles. 1995. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum. Mol. Genet. 4: 1569-1577.
-
(1995)
Hum. Mol. Genet.
, vol.4
, pp. 1569-1577
-
-
Williamson, M.P.1
Elder, P.A.2
Shaw, M.E.3
Devlin, J.4
Knowles, M.A.5
-
45
-
-
0023218482
-
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient
-
Wolf, C., I. Hayward, S. Lawrie, K. Buckton, M. McIntyre, D. Adams, A. Lewis, A. Scott, and J. Smyth. 1987. Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int. J. Cancer 39: 695-702.
-
(1987)
Int. J. Cancer
, vol.39
, pp. 695-702
-
-
Wolf, C.1
Hayward, I.2
Lawrie, S.3
Buckton, K.4
McIntyre, M.5
Adams, D.6
Lewis, A.7
Scott, A.8
Smyth, J.9
-
46
-
-
0030800135
-
Frequent gains and losses of specific chromosome segments in human ovarian carcinomas shown by comparative genomic hybridization
-
Wolff, E., T. Liehr, U. Vorderwulbecke, A.H. Tulusan, E.M. Husselein, E. Gebhart. 1997. Frequent gains and losses of specific chromosome segments in human ovarian carcinomas shown by comparative genomic hybridization. Int. J. Oncol. 11: 19-23.
-
(1997)
Int. J. Oncol.
, vol.11
, pp. 19-23
-
-
Wolff, E.1
Liehr, T.2
Vorderwulbecke, U.3
Tulusan, A.H.4
Husselein, E.M.5
Gebhart, E.6
-
47
-
-
0006713602
-
Identification of the breast cancer susceptibility gene BRCA2
-
published erratum appears in Nature 379: 749, 1996
-
Wooster, R., G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, and G. Micklem. 1995. Identification of the breast cancer susceptibility gene BRCA2. [published erratum appears in Nature 379: 749, 1996.] Nature 378: 789-792.
-
(1995)
Nature
, vol.378
, pp. 789-792
-
-
Wooster, R.1
Bignell, G.2
Lancaster, J.3
Swift, S.4
Seal, S.5
Mangion, J.6
Collins, N.7
Gregory, S.8
Gumbs, C.9
Micklem, G.10
-
48
-
-
0022572014
-
Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation
-
Yokota, J., Y. Tsunetsugu-Yokota, H. Battifora, C. Le Fevre, and M.J. Cline. 1986. Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science 231: 261-265.
-
(1986)
Science
, vol.231
, pp. 261-265
-
-
Yokota, J.1
Tsunetsugu-Yokota, Y.2
Battifora, H.3
Le Fevre, C.4
Cline, M.J.5
|